C

Haemonetics Corporation HAE

$108.52 -$0.21-0.19% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Haemonetics Corporation is a U.S.-based medical technology company that develops and provides products, software, and services focused on blood and plasma collection, hospital transfusion management, and hemostasis management. The company operates primarily within the healthcare technology and medical devices industries, serving blood centers, plasma collection organizations, hospitals, and surgical care providers. Its core revenue drivers include plasma collection systems, blood management technologies, hospital software platforms, and hemostatic management solutions used in surgical and critical care environments.

The company was founded in 1971 and is headquartered in Boston, Massachusetts. Haemonetics initially built its business around automated blood collection technologies and expanded over time into plasma collection systems, hospital transfusion software, and cardiovascular and surgical technologies through internal development and acquisitions. The company has established a strong market position in plasma collection, supported by long-standing relationships with major plasma collection operators and integrated technology platforms that combine devices, disposables, and software analytics.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Thursday, August 6, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 2 and 6 (est)

Price History

Loading...
52-Week Range97% of range
Low
$47.32
Current
$108.52
High
$110.45
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
781 848 7100
Address
125 Summer Street
Boston, MA 02110
Country
Year Founded

Headlines

8/31/2026 - Zacks Investment Research